Literature DB >> 22486802

Association between liver insulin resistance and cardiovascular risk factors.

J Vangipurapu1, A Stančáková, T Kuulasmaa, P Soininen, A J Kangas, M Ala-Korpela, J Kuusisto, M Laakso.   

Abstract

OBJECTIVES: The objective of this study was to examine the associations between indices of liver insulin resistance (IR) and whole-body insulin sensitivity and different cardiovascular disease (CVD) risk factors. DESIGN AND
SUBJECTS: A total of 8750 nondiabetic men (age 57.2 ± 7.1 years, body mass index 26.8 ± 3.8 kg m(-2) ) were included in this study from the population-based cross-sectional Metabolic Syndrome In Men (METSIM) cohort. Liver IR index and Matsuda insulin sensitivity index (ISI) were used as markers of liver IR and whole-body insulin sensitivity, respectively. Pearson correlation analysis was performed to examine the associations between these indices and various CVD risk factors.
RESULTS: Total cholesterol (r = -0.088 vs. r = 0.020; P < 0.0019), high-sensitivity C-reactive protein (CRP) (r = 0.284 vs. r = -0.219; P < 0.0019) and total triglycerides (r = 0.507 vs. r = -0.477; P < 0.05) were more highly correlated with liver IR index than with Matsuda ISI. By contrast, Matsuda ISI was nominally more highly correlated with systolic and diastolic blood pressure (r = -0.234 and r = -0.275 vs. r = 0.202 and r = 0.239, respectively) compared to liver IR index. Furthermore, the variance explained by liver IR index was larger than that explained by Matsuda ISI for the majority of CVD risk factors measured.
CONCLUSIONS: Liver IR index correlated more strongly than Matsuda ISI with levels of total cholesterol, CRP and triglycerides. Therefore, liver IR might be a significant indicator of CVD risk amongst men.
© 2012 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Mesh:

Year:  2012        PMID: 22486802     DOI: 10.1111/j.1365-2796.2012.02540.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  9 in total

1.  Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats.

Authors:  Xiang Qiu; Dan-Hong Gao; Xiao Xiang; Yu-Fang Xiong; Teng-Shi Zhu; Lie-Gang Liu; Xiu-Fa Sun; Li-Ping Hao
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

2.  Altered gene expression involved in insulin signaling pathway in type II diabetic osteoporosis rats model.

Authors:  Baoxin Li; Yan Wang; Yan Liu; Jianxia Ma; Yukun Li
Journal:  Endocrine       Date:  2012-07-22       Impact factor: 3.633

3.  High prevalence of cardiometabolic risk factors in Hispanic adolescents: correlations with adipocytokines and markers of inflammation.

Authors:  Cynthia M Pérez; Ana P Ortiz; Enrique Fuentes-Mattei; Guermarie Velázquez-Torres; Damarys Santiago; Katya Giovannetti; Raúl Bernabe; Mong-Hong Lee; Sai-Ching J Yeung
Journal:  J Immigr Minor Health       Date:  2014-10

4.  Association between new markers of cardiovascular risk and hepatic insulin resistance in those at high risk of developing type 2 diabetes.

Authors:  Lucilla D Monti; Camillo Bechi Genzano; Barbara Fontana; Elena Galluccio; Serena Spadoni; Andrea Magistro; Emanuele Bosi; Piermarco Piatti
Journal:  Endocrine       Date:  2021-09-21       Impact factor: 3.633

5.  Regulation of DMT1 on Bone Microstructure in Type 2 Diabetes.

Authors:  Wei-Lin Zhang; Hong-Zheng Meng; Mao-Wei Yang
Journal:  Int J Med Sci       Date:  2015-05-26       Impact factor: 3.738

6.  Melatonin suppresses autophagy in type 2 diabetic osteoporosis.

Authors:  Wei-Lin Zhang; Hong-Zheng Meng; Rui-Fei Yang; Mao-Wei Yang; Guang-Hong Sun; Jun-Hua Liu; Peng-Xu Shi; Fei Liu; Bo Yang
Journal:  Oncotarget       Date:  2016-08-09

7.  NIPA2 regulates osteoblast function by modulating mitophagy in type 2 diabetes osteoporosis.

Authors:  Wei Zhao; Weilin Zhang; Hongdong Ma; Maowei Yang
Journal:  Sci Rep       Date:  2020-02-20       Impact factor: 4.379

8.  Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: rationale and design of the epidemiological studies within the IMI DIRECT Consortium.

Authors:  Robert W Koivula; Alison Heggie; Anna Barnett; Henna Cederberg; Tue H Hansen; Anitra D Koopman; Martin Ridderstråle; Femke Rutters; Henrik Vestergaard; Ramneek Gupta; Sanna Herrgård; Martijn W Heymans; Mandy H Perry; Simone Rauh; Maritta Siloaho; Harriet J A Teare; Barbara Thorand; Jimmy Bell; Søren Brunak; Gary Frost; Bernd Jablonka; Andrea Mari; Tim J McDonald; Jacqueline M Dekker; Torben Hansen; Andrew Hattersley; Markku Laakso; Oluf Pedersen; Veikko Koivisto; Hartmut Ruetten; Mark Walker; Ewan Pearson; Paul W Franks
Journal:  Diabetologia       Date:  2014-04-04       Impact factor: 10.122

Review 9.  Quantitative Serum Nuclear Magnetic Resonance Metabolomics in Large-Scale Epidemiology: A Primer on -Omic Technologies.

Authors:  Peter Würtz; Antti J Kangas; Pasi Soininen; Debbie A Lawlor; George Davey Smith; Mika Ala-Korpela
Journal:  Am J Epidemiol       Date:  2017-11-01       Impact factor: 4.897

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.